Biosynthesis and function of β 1,6 branched mucin-type glycans

Advances in Experimental Medicine and Biology

Volumn 491, Issue , 2001, Pages 279-312

  Beum, P V ^a   Cheng, P W ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; GLYCAN DERIVATIVE; MUCIN;

5' UNTRANSLATED REGION; AMINO ACID SEQUENCE; BLOOD GROUP LEWIS SYSTEM; CARBOHYDRATE ANALYSIS; CELL SURFACE; CONFERENCE PAPER; ENZYME ACTIVITY; INFLAMMATION; METASTASIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION;

EID: 0034955109     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-1267-7_19     Document Type: Conference Paper

References (167)

1. A family of UDP-GalNAc: Polypeptide N-acetylgalactosaminyltransferases control the initiation of mucin-type O-linked glycosylation
2. The specificity of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase as inferred from a database of in vivo substrates and from the in vitro glycosylation of proteins and peptides
3. The acceptor specificity of porcine submaxillary UDP-GalNAc: Polypeptide N-acetylgalactosaminyltransferase is dependent on the amino acid sequences adjacent to serine and threonine residues
4. Substrate specificities of three members of the human UDP- N-acetyl-α-D-galactosamine: Polypeptide N-acetylgalactosaminyltransferase Family, GalNAc-T1, -T2, and -T3
5. Influence of acceptor substrate primary amino acid sequence on the activity of human UDP-N-acetylgalactosamine: Polypeptide N-acetylgalactosaminyltransferase. Studies with the MUCl tandem repeat
6. Structures of the O-glycans on P-selectin glycoprotein ligand-1 from HL-60 cells
7. a substances: Possible sugar sequences in the carbohydrate chains
8. Glycosyltransferases involved in N- and O-glycan biosynthesis
9. Concepts and principles of O-linked glycosylation
10. Mucin-type glycoproteins
11. The biosynthesis of serine (threonine)-N-acetylgalactosamine-linked carbohydrate moieties
12. Biosynthesis and functions of O-glycans and regulation of mucin antigen expression in cancer
13. Expression of the developmental I antigen by a cloned human cDNA encoding a member of a β-1,6-N-acetylglucosaminyltransferase gene family
14. Expression cloning of a cDNA encoding UDP-GlcNAc:Galβ1-3GalNAc-R(GlcNAc-to-GalNAc)β1-6 GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen
15. Control of O-glycan branch formation: Molecular cloning and characterization of a novel thymus-associated core 2 β1,6-N-acetylglucosaminyltransferase
16. Control of O-glycan branch formation. Molecular cloning of human cDNA encoding a novel β-1,6-N-acetylglucosaminyltransferase forming core 2 and core 4
17. Molecular cloning and expression of a novel β-1,6-N-acetylglucosaminyltransferase that forms core 2, core 4 and I branches
18. Mucin synthesis. I. Detection in canine submaxillary glands of an N-acetylglucosaminyltransferase which acts on mucin substrates
19. Mucin synthesis. II. Substrate specificity and product identification studies on canine submaxillary glandUDP-GlcNAc:Galβ1-3GalNAc(GlcNAc-to-GalNAc)β6- acetylglucosaminyltransferase
20. Processing O-glycan core 1, Galβ1-3GalNAcα-R. Specificities of core 2, UDP-GlcNAc:Galβ1-3GalNAc-R(GlcNAc-to-GalNAc)β6-N- acetylglucosaminyltransferase and CMP-sialic acid: Galβ1-3GalNAc-Rα 2-3-sialyltransferase
21. Evaluation of deoxygenated oligosaccharide acceptor analogs as specific inhibitors of glycosyltransferases
22. Mucin biosynthesis. Characterization of rabbit small intestinal UDP-N-acetylglucosamine:Galactose β-3-N-acetylgalactosaminide (N-acetylglucosamine-to-N-acetylgalactosamine) β-6-N-acetylglucosaminyl-transferase
23. Mucin biosynthesis. Properties of a bovine tracheal mucin β-6-N-acetylglucosaminyltransferase
24. UDP-GlcNAc:Galβ3GalNAc-mucin: (GlcNAc-to-GalNAc) β6-N-acetylglucosaminyltransferase and UDP-GlcNAc:Galβ3(GlcNAcβ6) GalNAc-mucin (GlcNAc-to-Gal)β3-N-acetylglucosaminyltransferase from swine trachea epithelium
25. UDP-GlcNAc:GalNAc-R β3-N-acetylglucosaminyltransferase and UDP-GlcNAc: GlcNAcβ1-3GalNAc-R(GlcNAc-to-GalNAc)β6-N- acetylglucosaminyltransferase from pig and rat colon mucosa
26. 2 by a β6-N-acetylglucosaminyltransferase in pig gastric mucosa
27. Mucin biosynthesis. Purification and characterization of a mucin β6N-acetylglucosaminyltransferase
28. Type-specific cold auto-antibodies as a cause of acquired hemolytic anemia and hemolytic transfusion reactions: Biologic test with bovine red cells
29. Anti-i: A cold antibody defining the Ii relationship in human red cells
30. b specificities
31. b blood group system-hemagglutination-inhibition studies
32. Immunochemical studies on blood groups. XLIX. The I antigen complex: Specificity differences among anti-I sera revealed by quantitative precipitin studies; partial structures of the I determinant specific for one anti-I serum
33. On neutral fucoglycolipids having long, branched carbohydrate chains: H-active and I-active glycosphingolipids of human erythrocyte membranes
34. Blood group I activities of synthetic oligosaccharides assessed by radioimmunoassay
35. Blood group i and I activities of "lacto-N-norhexaosylceramide" and its analogues: The structural requirements for i-specificities
36. Developmental change and genetic defect in the carbohydrate structure of Band 3 glycoprotein of human erythrocyte membrane
37. Glycolipid antigens with blood group I and i specificities from human adult and umbilical cord erythrocytes
38. Structure of branched lactosaminoglycan, the carbohydrate moiety of Band 3 isolated from adult human erythrocytes
39. Novikoff ascites tumor cells contain N-acetyllactosaminide β1-3 and β1-6 N-acetylglucosaminyltransferase activity
40. Biosynthesis in vitro of Ii core glycosphingolipids from neolactotetraosylceramide by β1-3- and β1-6-N-acetylglucosaminyltransferases from mouse T-lymphoma
41. The occurrence of two novel N- acetylglucosaminyltransferase activities in human serum
42. Sera of i subjects have the capacity to synthesize the branched GlcNAcβ1,6[GlcNAcβ1,3]Gal structure
43. Biosynthesis of blood group I antigens: Identification of a UDP-GlcNAc:GlcNAcβ1-3Gal(-R)β1-6(GlcNAc to Gal) N-acetylglucosaminyltransferase in hog gastric mucosa
44. The β1,6-GlcNAc transferase activity present in hog gastric mucosal microsomes catalyses site-specific branch formation on a long polylactosamine backbone
45. Biosynthesis of polylactosaminoglycans. Novikoff ascites tumor cells contain two UDP-GlcNAc:β-galactoside β1,6-N-acetylglucosaminyltransferase activities
46. A series of disialogangliosides with binary 2-3 sialosyllactosamine structure, defined by monoclonal antibody NUH2, are oncodevelopmentally regulated antigens
47. Immunochemistry of I/i-active oligo- and polyglycosylceramides from rabbit erythrocyte membranes. Characterization of linear, di-, and triantennary neolactoglycosphingolipids
48. 1H NMR spectroscopy
49. Isolation and characterization of an I-active ceramide decasaccharide from rabbit erythrocyte membranes
50. Isolation and characterization of a novel fucoganglioside of human erythrocyte membrane
51. Isolation and characterization of gangliosides with a new sialosyl linkage and core structures. II. Gangliosides of human erythrocyte membranes
52. Human serum contains a novel β1-6 N-acetylglucosaminyltransferase activity that is involved in midchain branching of oligo(N-acetyllactosaminoglycans)
53. Purification and characterization of UDP-GlcNAc:Galβ14-GlcNAcβ1-3Galβ1-4Glc(NAc)-R(GlcNAc to Gal) acting β1,6-N-acetylglucosaminyltransferase from hog small intestine
54. Biosynthesis of blood group I and i antigens in rat tissues: Identification of a novel β1-6-N-acetylglucosaminyltransferase
55. In vitro biosynthesis of a decasaccharide prototype of multiply branched polylactosaminoglycan backbones
56. The centrally acting β-1,6-N-acetylglucosaminyltransferase (GlcNAc to Gal): Functional expression, purification, and acceptor specificity of a human enzyme involved in midchain branching of linear poly-N-acetyllactosamines
57. Regulation of I-branched poly-N-acetyllactosamine synthesis: Concerted actions by i-extension enzyme, I-branching enzyme, and β1,4-galactosyltransferase
58. Embryonal lactosaminylglycan: The structure of branched lactosaminoglycans with novel disialosyl (sialyl α2-9 sialyl) terminals isolated from PA1 human embryonic carcinoma cells
59. Polyglycosylceramides with branched N-acetylactosamine sequences are synthesized by the human pancreatic carcinoma cell line Panc-1
60. 1H nuclear magnetic resonance
61. Elongation of both branches of biantennary backbones of oligo-(N-acetyllactosamino)glycans by human serum 1,3-N-acetyl-β-D-glucosaminyltransferase
62. Enzymatic in vitro synthesis of radiolabeled pentadecasaccharides GlcNAc β1,3(Galβ1,4GlcNAcβ1,6)Gal β1,4GlcNAc/Glc and the isomeric Galβ1,4GlcNAc β1,3(GlcNAcβ1,6)Gal β1,4GlcNAc/Glc
63. Biosynthesis of blood-group I and i substances. Specificity of bovine colostrum β-N-acetyl-D-glucosaminide β 1,4 galactosyltransferase
64. Isolation and characterization of a pseudogene related to human core 2 β1-6 N-acetylglucosaminyltransferase
65. Tissue-specific regulation of mouse core 2 β-1,6-N-acetylglucosaminyltransferase
66. Mucin biosynthesis: Molecular cloning and expression of bovine lung mucin core 2 N-acetylglucosaminyltransferase cDNA
67. Development of monoclonal antibodies against bovine mucin core 2 β6 N-acetylglucosaminyltransferase
68. Identification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissues
69. Expression cloning of cDNA encoding a human β-1,3-N-acetylglucosaminyltransferase that is essential for poly-N-acetyllactosamine synthesis
70. Genomic organization of core 2 and I branching β-1,6-N-acetylglucosaminyltransferases. Implications for evolution of the β-1,6-N-acetylglucosaminyltransferase gene family
71. Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis
72. A multipotential β-1,6-N-acetylglucosaminyltransferase is encoded by bovine herpesvirus type 4
73. Expression of stable human O-glycan core 2 β-1,6-N-acetylglucosaminyltransferase in Sf9 insect cells
74. Structures of O-linked oligosaccharides isolated from normal granulocytes, chronic myelogenous leukemia cells, and acute myelogenous leukemia cells
75. x structures in O-glycans
76. Increased UDP-GlcNAc:Galβ1-3GalNAc-R(GlcNAc-to-GalNAc)β1,6-N- acetylglucosaminyltransferase activity in metastatic murine tumor cell lines
77. Branching β1,6-N-acetylglucosaminyltransferases and polylactosamine expression in mouse F9 teratocarcinoma cells and differentiated counterparts
78. Structural analysis of murine zona pellucida glycans. Evidence for the expression of core 2-type O-glycans and the Sd(a) antigen
79. Expression of a differentiation antigen and poly-N-acetyllactosaminyl O-glycans directed by a cloned core 2 β1,6-N-acetylglucosaminyltransferase
80. Structural study of the O-linked sugar chains of human leukocyte tyrosine phosphatase CD45
81. Leukocyte trafficking mediated by selectin-carbohydrate interactions
82. Selectin ligands
83. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
84. Selectin-carbohydrate interactions and the initiation of the inflammatory response
85. The P-selectin glycoprotein ligand from human neutrophils displays sialylated, fucosylated, O-linked poly-N-acetyllactosamine
86. Characterization of the O-linked oligosaccharide structures on P-selectin glycoprotein ligand-1 (PSGL-1)
87. Post-translational modifications of recombinant P-selectin glycoprotein ligand-1 required for binding to P- and E-selectin
88. Core 2 β-1,6-N-acetylglucosaminyltransferase enzyme activity is critical for P-selectin glycoprotein ligand-1 binding to P-selectin
89. Structure of the O-glycans in GlyCAM-1, an endothelial-derived ligand for L-selectin
90. x expression level in human pre-B lymphocytic leukemia cell line KM3 treated with phorbol ester
91. Core 2-containing O-glycans on CD43 are preferentially expressed in the memory subset of human CD4 T cells
92. Human T lymphocyte populations which bind to P- or E-selectin are enriched with cells expressing core 2 O-glycans
93. x expression during activation of human tonsillar B lymphocytes
94. Carcinoma-associated expression of core 2 β-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: Role of O-glycans in tumor progression
95. Core 2 oligosaccharide biosynthesis distinguishes between selectin ligands essential for leukocyte homing and inflammation
96. Two distinct core structures that form L-selectin ligands
97. Cell surface glycoproteins of murine cytotoxic T lymphocytes. T 145, a new cell surface glycoprotein selectively expressed on Ly 1-2+ cytotoxic T lymphocytes
98. Activated human T lymphocytes display new surface glycoproteins
99. Modification of CD43 and other lymphocyte O-glycoproteins by core 2 β-1,6-N-acetylglucosaminyltransferase
100. Specific CD45 isoforms differentially regulate T cell receptor signaling
101. CD44 plays a costimulatory role in murine T cell adhesion: Ligation of CD44 selectively costimulates IL-2 production, but not proliferation in TCR-stimulated murine Th1 cells
102. CD43 is a murine T cell costimulatory receptor that functions independently of CD28
103. Human thymic epithelial cells express an endogenous lectin, galectin-1, which binds to core 2 O-glycans on thymocytes and T lymphoblastoid cells
104. The CD43 130-kD peripheral T-cell activation antigen is downregulated in thymic positive selection
105. Branched O-linked oligosaccharides ectopically expressed in transgenic mice reduce primary T-cell immune response
106. Overexpression of branched O-linked oligosaccharides on T cell surface glycoproteins impairs humoral immune responses in transgenic mice
107. GlcNAc-transferase V and core 2 GlcNAc-transferase expression on the developing mouse embryo
108. Regulation of UDP-GlcNAc:Galβ1-3GalNAc-Rβ1,6-N-acetylglucosaminyltransferase (GlcNAc-to-GalNAc) in Chinese hamster ovary cells
109. Expression of the H type I blood group antigen during enterocytic differentiation of Caco-2 cells
110. Induction of glycosyltransferases on Caco-2 cells by sodium butyrate
111. Morphological abnormalities in the lymphocytes of patients with the Wiskott-Aldrich syndrome
112. The Wiskott-Aldrich syndrome in the United States and Canada (1892-1979)
113. The primary immunodeficiencies
114. The Wiskott-Aldrich syndrome: Studies of lymphocytes, granulocytes, and platelets
115. Surface protein abnormalities in lymphocytes and platelets from patients with Wiskott-Aldrich syndrome
116. Characterization of the human lymphocyte surface sialoglycoprotein that is defective in Wiskott-Aldrich syndrome
117. Enhancement of T-cell activation by the CD43 molecule whose expression is defective in Wiskott-Aldrich syndrome
118. Targeted disruption of CD43 gene enhances T lymphocyte adhesion
119. Altered O-glycan synthesis in lymphocytes from patients with Wiskott-Aldrich syndrome
120. Aberrant O-linked oligosaccharide biosynthesis in lymphocytes and platelets from patients with the Wiskott-Aldrich syndrome
121. O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer
122. Alterations of O-glycan biosynthesis in human colon cancer tissues
123. Biosynthesis of O-glycans in leukocytes from normal donors and from patients with leukemia: Increase in O-glycan core 2 UDP-GlcNAc:Galβ3GalNAcα-R (GlcNAc to GalNAc) β1,6-N-acetylglucosaminyltransferase in leukemic cells
124. Structures of neutral O-linked polylactosaminoglycans on human skim milk mucins. A novel type of linearly extended poly-N-acetyllactosamine backbone with Galβ1-4GlcNAcβ1,6 repeating units
125. Oligosaccharide differences in the DF3 sialomucin antigen from normal human milk and the BT-20 human breast carcinoma cell line
126. Comparison of O-linked carbohydrate chains in MUCl mucin from normal breast epithelial cell lines and breast carcinoma cell lines. Demonstration of simpler and fewer glycan chains in tumor cells
127. Mechanisms underlying aberrant glycosylation of MUCl mucin in breast cancer cells
128. A transfected sialyltransferase that is elevated in breast cancer and localizes to the medial/trans-golgi apparatus inhibits the development of core 2-based O-glycans
129. Expression of core 2 β-1,6-N-acetylglucosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUCl tumor-associated epitopes
130. Oligosaccharides expressed on MUCl produced by pancreatic and colon tumor cell lines
131. Altered glycosylation of leukosialin, CD43, in HIV-1-infected cells of the CEM line
132. Activity levels of a β1,6-N-acetylglucosaminyltransferase in lymphomonocytes from multiple sclerosis patients
133. Overexpression of core 2 β1,6-N-acetylglycosaminyltransferase enhances cytokine actions and induces hypertrophic myocardium in transgenic mice
134. Circulating antibodies against an exocrine pancreatic enzyme in type 1 diabetes
135. Isolation and characterization of polyglycosylceramides (megaloglycolipids) with A, H and I blood-group activities
136. Erythroglycan, a high molecular weight glycopeptide with the repeating structure [galactosy-1,4-2-deoxy-2-acetamido-glucosyl-1,3] comprising more than one third of the protein-bound carbohydrate of human erythrocyte stroma
137. Ganglioside and rabbit erythrocyte membrane receptor for staphylococcal alpha-toxin
138. Isolation and characterization of receptor sialoglycoprotein for hemagglutinating virus of Japan (Sendai virus) from bovine erythrocyte membrane
139. Erythrocyte receptors for Mycoplasma pneumoniae are sialylated oligosaccharides of Ii antigen type
140. Identification of an active disaccharide unit of a glycoconjugate receptor for Pneumococci attaching to human pharyngeal epithelial cells
141. Monogamous bivalency of IgG antibodies. I. Deficiency of branched ABHI-Active oligosaccharide chains on red cells of infants causes the weak antiglobulin reactions in hemolytic disease of the newborn due to ABO incompatibility
142. Antibody affinity. VII. Multivalent interaction of anti-lactoside antibody
143. Antibody affinity. III. The role of multivalence
144. The influence of polyvalency on the binding properties of antibodies
145. A multivalent lacto-N-fucopentaose III-lysyllysine conjugate decompacts preimplantation mouse embryos, while the free oligosaccharide is ineffective
146. Enzyme-assisted synthesis of a bivalent high-affinity dodecasaccharide inhibitor of mouse gamete adhesion. The length of the chains carrying distal α1,3-bonded galactose residues is critical
147. x: Potent inhibitors of E-selectin-mediated cell adhesion; reagent for staining activated endothelial cells
148. L-selectin ligands in rat high endothelium: Multivalent sialyl Lewis x glycans are high-affinity inhibitors of lymphocyte adhesion
149. Synthesis of a tetravalent sialyl Lewis x glycan, a high-affinity inhibitor of L-selectin-mediated lymphocyte binding to endothelium
150. Synthesis of a divalent sialyl Lewis x O-glycan, a potent inhibitor of lymphocyte-endothelium adhesion. Evidence that multivalency enhances the saccharide binding to L-selectin
151. x oligosaccharide in inhibiting L-selectin-dependent lymphocyte adhesion
152. x determinants to L-selectin in high-affinity mode
153. Status of blood group carbohydrate chains in ontogenesis and in oncogenesis
154. Immunochemistry of Ii-active glycolipids of erythrocytes
155. Structure of fetal lactosaminoglycan: The carbohydrate moiety of Band 3 isolated from human umbilical cord erythrocytes
156. Glycolipids of fetal, newborn, and adult erythrocytes: Glycolipid pattern and structural study of H3-glycolipid from newborn erythrocytes
157. Carbohydrate structure and cell differentiation: Unique properties of fucosyl-glycopeptides isolated from embryonal carcinoma cells
158. Changes in the expression and polarization of blood group I and i antigens in post-implantation embryos and teratocarcinomas of mouse associated with cell differentiation
159. Sequential change of carbohydrate antigen associated with differentiation of murine leukemia cells: i-I antigenic conversion and shifting of glycolipid synthesis
160. Membrane differentiation in human erythroid cells: Unique profiles of cell surface glycoproteins expressed in erythroblasts in vitro from three ontogenic stages
161. Immunologic relationship between blood group substances and a fucose-containing glycolipid of human adenocarcinoma
162. Tissue isoantigens A, B, and H in carcinoma of the stomach
163. Blood-group precursors and cancer-related antigens
164. b antigens and the blood group precursor associated I (Ma) antigen in glycoprotein-rich extracts of gastric carcinomas
165. Peanut lectin and anti-Ii antibodies reveal structural differences among human gastrointestinal glycoproteins
166. Sytnesis of type 1 and 2 lacto series glycolipid antigens in human colonic adenocarcinoma and derived cell lines is due to activation of a normally unexpressed β1-3N-acetylglucosaminyltransferase